title: When do the federal regulations allow placebo-controlled trials in children?
authors.affiliation: Department of Clinical Bioethics, National Institutes of Health, Bethesda, Maryland, USA. fmiller@nih.gov
authors.forename: Franklin G
authors.initials: FG
authors.lastname: Miller
authors.forename: David
authors.initials: D
authors.lastname: Wendler
authors.forename: Benjamin
authors.initials: B
authors.lastname: Wilfond
mesh_terms: D002648:Child; D002651:Child Advocacy / Q000941:ethics / Q000331:legislation & jurisprudence; D018849:Controlled Clinical Trials as Topic / Q000009:adverse effects* / Q000941:ethics / Q000331:legislation & jurisprudence / Q000592:standards*; D028744:Ethics Committees, Research; D032984:Ethics, Research; D033161:Government Regulation; D006805:Human Experimentation / Q000941:ethics / Q000331:legislation & jurisprudence / Q000592:standards*; D006801:Humans; D009316:National Institutes of Health (U.S.) / Q000458:organization & administration; D016134:Organizational Policy; D018579:Patient Selection / Q000941:ethics; D010919:Placebos; D018570:Risk Assessment / Q000941:ethics / Q000331:legislation & jurisprudence / Q000379:methods; D014481:United States; D014486:United States Food and Drug Administration / Q000458:organization & administration
chemical_list: D010919:Placebos